Acadia Pharmaceuticals reported $139.83M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
ALKERMES ALKS:US $ 254.65M 27.91M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Biogen BIIB:US $ 2646.6M 897.3M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Cara Therapeutics CARA:US $ 46.72M 25.36M
Corcept Therapeutics CORT:US $ 35.35M 26.52M
Cytokinetics CYTK:US $ 93.63M 21.79M
Eisai 4523:JP Y 287815M 23426M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
Intra Cellular Therapies ITCI:US $ 77.24M 52.06M
Marinus Pharmaceuticals MRNS:US $ 92.33M 33.99M
Moderna Inc MRNA:US 2.87B 2.18B
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Prothena PRTA:US $ 508.8M 34.2M
Ptc Therapeutics PTCT:US $ 158.16M 13.98M
Sarepta Therapeutics SRPT:US $ 868.56M 365.31M
Seattle Genetics SGEN:US $ 364.87M 103.88M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vanda Pharmaceuticals VNDA:US $ 58.23M 8.7M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M
YTE INCY:US $ 2435.38M 178.62M